MacuTherm Performance Study in Patients With iAMD

计划入组 240 人 · 首次发布于 2026 年 5 月 26 日

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

计划入组 116 人 · 首次发布于 2022 年 1 月 27 日

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

计划入组 735 人 · 首次发布于 2022 年 6 月 7 日

IAMA-003

IAMA-097

IAMA-005

AMD Medicom Inc

Canada

AMD RITMED MEDICOM

United States

MACUSTAR Study Validates Novel Endpoints for Age-Related Macular Degeneration Clinical Trials

OCT Biomarkers Distinguish Progression to Neovascular vs. Atrophic AMD in Intermediate Disease

Real-World Study Shows Faricimab Improves Outcomes in nAMD Patients